This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Ultibro Breezhaler
  • /
  • QVA vs. Salmeterol/Fluticasone, 52-week Exacerbati...
Clinical trial

QVA vs. Salmeterol/Fluticasone, 52-week Exacerbation Study, FLAME (EFfect of Indacaterol Glycopyronium Vs Fluticasone Salmeterol on COPD Exacerbations)

Read time: 1 mins
Last updated:1st Jul 2013
Register free for full access to medthority.com